GBP1 has been reported to be associated with better prognosis in colorectal cancer, liver cancer, epithelial ovarian cancer, triple negative breast cancer, cutaneous melanoma and other cancers [12–14, 25–27]. This evidence concerns the gene GBP1 and cutaneous melanoma.